Table 1 Characteristics of study participants
Number | 173 | Â |
|---|---|---|
| Â | Mean (SD) | KS Z |
Age (years) | 57.1 (10.1) | 0.874 |
Weight (kg) | 76.2 (12.1) | 0.875 |
Height (cm) | 155.5 (5.4) | 0.966 |
Body mass index (kg/m2) | 31.1 (4.8) | 0.770 |
Joint space width | 3.2 (1.2) | 0.910 |
EQ 5D index at baseline | 0.2 (0.1) | 0.984 |
EQ 5D after treatment | 0.6 (0.3) | 0.822 |
VAS EQ 5D at baseline | 40 (18) | 0.604 |
VAS EQ 5D after treatment | 67 (18) | 0.597 |
WOMAC at baseline | 66 (20) | 0.595 |
WOMAC after treatment | 34 (17) | 0.628 |
| Â | Median (quartiles) | Â |
WOMAC raw change within transition scale at endpoint | Â | Â |
   Much better | 13 (12-22) | 5.574* |
   Slightly better | 28 (13-39) | 3.765* |
   No change | 17 (8-22) | 5.318* |
   Slightly worse | 1 (-8-11) | 6.450* |
Number of pregnancies | 4(1-6) | 1.366* |
Duration of OA (month) | 4 (2-10) | 2.001* |
| Â | N(%) | Â |
Female | 125 (72.3) | - |
Existence of previous knee injuries | 26 (15.1) | - |
Existence of back pain | 58 (33.5) | - |
Co morbidities | 101 (58.4) | - |
Smokers | 12 (6.9) | - |
High level of education | 61 (35.3) | - |